Decitabine azacitidine
由 BH Lee 著作 · 2020 · 被引用 7 次 — Decitabine treatment showed significantly better ORR than azacitidine treatment (odds ratio, 1.943; 95% CI, 1.203–3.139; P = 0.007; random ... ,The hypomethylating agents decitabine and azacitidine have been found to improve the outcome of patients with myelodysplastic syndrome (MDS); however, ...
| 相關軟體 HMA! Pro VPN 資訊 | |
|---|---|
 Decitabine azacitidine 相關參考資料
Azacitidine Vs. Decitabine in Unfit Newly Diagnosed Acute ...
由 M Alsina 著作 · 2020 · 被引用 25 次 — Background:Options to treat elderly patients with newly diagnosed AML include intensive, attenuated chemotherapy, hypomethylating agents ... https://ashpublications.org Comparison between 5-day decitabine and 7-day azacitidine ...
由 BH Lee 著作 · 2020 · 被引用 7 次 — Decitabine treatment showed significantly better ORR than azacitidine treatment (odds ratio, 1.943; 95% CI, 1.203–3.139; P = 0.007; random ... https://www.nature.com Comparison between decitabine and azacitidine ... - NCBI - NIH
The hypomethylating agents decitabine and azacitidine have been found to improve the outcome of patients with myelodysplastic syndrome (MDS); however, ... https://www.ncbi.nlm.nih.gov Comparison between decitabine and azacitidine for ... - PubMed
由 M Xie 著作 · 2015 · 被引用 49 次 — The hypomethylating agents decitabine and azacitidine have been found to improve the outcome of patients with myelodysplastic syndrome (MDS); however, ... https://pubmed.ncbi.nlm.nih.go Concise Drug Review: Azacitidine and Decitabine - NCBI - NIH
由 EJB Derissen 著作 · 2013 · 被引用 186 次 — Azacitidine and decitabine (5-aza-2′deoxycytidine) are cytidine analogs in which the carbon atom at position 5 in the pyrimidine ring has been replaced by a .... https://www.ncbi.nlm.nih.gov Concise drug review: azacitidine and decitabine - PubMed
由 EJB Derissen 著作 · 2013 · 被引用 186 次 — The introduction of the hypomethylating agents azacitidine and decitabine has been a major advancement in the treatment of patients with higher-risk ... https://pubmed.ncbi.nlm.nih.go Safety and preliminary efficacy of venetoclax with decitabine ...
由 CD DiNardo 著作 · 2018 · 被引用 390 次 — Safety and preliminary efficacy of venetoclax with decitabine or azacitidine in elderly patients with previously untreated acute myeloid leukaemia: a non- ... https://pubmed.ncbi.nlm.nih.go Venetoclax combined with decitabine or azacitidine ... - PubMed
由 CD DiNardo 著作 · 2019 · 被引用 784 次 — Older patients with acute myeloid leukemia (AML) respond poorly to standard induction therapy. B-cell lymphoma 2 (BCL-2) overexpression is ... https://pubmed.ncbi.nlm.nih.go Venetoclax combined with decitabine or azacitidine in ...
Venetoclax combined with decitabine or azacitidine in treatment-naive, elderly patients with acute myeloid leukemia. Clinical Trials & Observations. Courtney D. https://ashpublications.org |